Clinical Trials Browser

Phase 2 × Extensive Stage Small Cell Lung Cancer × camrelizumab × Clear all

NCT04790539 2021-03-10

a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung Cancer

Phase 2 Unknown

Extensive Stage Small Cell Lung Cancer